Captain's Quarters

[JD400]

3 Ups VERI CHRS XPLR


Ticker VERI [NASD]


Company Veritone, Inc.
Country USA
Industry Application Software
Market Cap 122.77M EPS (ttm) -4.77
P/E - EPS this Y -216.40%
Forward P/E - EPS next Y 60.90%
PEG - EPS past 5Y -
P/S 10.23 EPS next 5Y 20.00%
P/B 1.20 EPS Q/Q -264.50%
Dividend - Sales Q/Q 0.00%
Insider Own 51.90% Inst Own 8.60%
Insider Trans - Inst Trans -
Short Float 3.81% Earnings Aug 07/a
Analyst Recom 2.00 Target Price 17.00
Avg Volume 84.36K 52W Range 7.76 - 15.64
Aug-18-17 11:46PM [$$] Artificial Intelligence Gets a Lot Smarter Barrons.com
Aug-14-17 12:00PM Veritone Expands Relativity Integration with Advanced e-Discovery Language Translation Business Wire
Aug-07-17 04:05PM Veritone Reports Financial Results for the Second Quarter and First Six Months of 2017 Business Wire
Aug-03-17 11:43AM Veritone Conductor Produces Significant Accuracy Gains, Affirming that Orchestrated, Multi-Engine Cognition is the Future of Artificial Intelligence Business Wire
Aug-01-17 08:34AM Liolios 6th Annual Gateway Conference to Showcase 100 Companies at the Four Seasons San Francisco on September 6-7 GlobeNewswire
Jul-31-17 08:00AM Veritone to Present at the 37th Annual Canaccord Genuity Growth Conference on August 9, 2017 Business Wire
Jul-21-17 08:00AM Veritone Sets Second Quarter 2017 Earnings Call for Monday, August 7, 2017 at 4:30 p.m. EDT Business Wire
Jul-19-17 09:00AM LegalZoom Broadens Relationship with Veritone One to Include Local and National Advertising Campaigns Business Wire
Jul-13-17 09:00AM Veritone and B6A Collaborate to Deliver Unique Video Analytics and Insights with Artificial Intelligence Business Wire
Jul-05-17 08:15AM Earnings Review and Free Research Report:

Veritone's Quarterly Revenue Soared 50% Accesswire


Veritone, Inc., a cloud-based cognitive software company, develops a proprietary artificial intelligence platform for various markets in the United States and internationally. Its cloud-based open platform integrates and orchestrates an ecosystem of cognitive engines to reveal multivariate insights from various amounts of audio, video, and structured data; and incorporates proprietary technology to manage and integrate a range of AI processes to mimic human cognitive functions comprising perception, reasoning, prediction, and problem solving to transform unstructured data into structured data. The company offers media agency services, including media planning and strategy, media buying and placement, campaign messaging, clearance verification and attribution, and custom analytics to manage, deliver, optimize, verify, and quantify advertising campaigns and content distribution for various clients across multiple channels comprising broadcast radio, satellite audio, streaming audio, broadcast and cable television, digital video, and podcasting. It also provides Software-as-a-Service solutions for media owners and broadcasters to automatically index and organize audio and video content to search, discover, and analyze their media for programming and optimization; political organizations to analyze public and private media, conduct research, and provide access to previously inaccessible data; legal professionals to find the critical details of their cases by storing, organizing, and analyzing evidentiary media; and police and other government authorities to organize and gain insight from the large amount of audio, video, and structured data they accumulate on a daily basis, as well as offers solutions for other markets, including commercial security and retail. The company was formerly known as Veritone Delaware, Inc. and changed its name to Veritone, Inc. in July 2014. Veritone, Inc. was founded in 2014 and is headquartered in Newport Beach, California.

Ticker CHRS [NASD]


Company Coherus Biosciences, Inc.
Country USA
Industry Biotechnology
Market Cap 582.75M EPS (ttm) -2.70
P/E - EPS this Y 49.50%
Forward P/E - EPS next Y -
PEG - EPS past 5Y -44.33%
P/S 3.53 EPS next 5Y 2.00%
P/B 17.62 EPS Q/Q 37.20%
Dividend - Sales Q/Q -90.10%
Insider Own 0.50% Inst Own 91.90%
Insider Trans 0.00% Inst Trans 4.98%
Short Float 13.02% Earnings Aug 07/a
Analyst Recom 3.00 Target Price 7.35
Avg Volume 791.88K 52W Range 10.80 - 31.98
Aug-21-17 12:39PM Coherus Bio Jumps on Private Placement 24/7 Wall St.
Aug-21-17 08:30AM Coherus Secures Private Placement from Temasek GlobeNewswire
Aug-21-17 08:05AM See what the IHS Markit Score report has to say about Coherus BioSciences Inc. Markit
Aug-13-17 10:05AM Edited Transcript of CHRS earnings conference call or presentation 8-May-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-17 11:46AM Here's Why Coherus Biosciences Rose as Much as 22.2% Today Motley Fool
Aug-07-17 11:58PM Coherus BioSciences reports 2Q loss Associated Press
Aug-07-17 04:00PM Coherus BioSciences Reports Second Quarter 2017 Corporate Highlights and Financial Results GlobeNewswire
Aug-07-17 10:20AM Investor Network: Coherus BioSciences, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-17 09:00AM Coherus BioSciences Files Petition for Inter Partes Review of ENBREL® Patent 8,163,522 GlobeNewswire
Jul-24-17 09:00AM Coherus BioSciences to Report Second Quarter 2017 Financial Results on August 7th GlobeNewswire
Coherus BioSciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. The company's product candidates include CHS-1701, a pegfilgrastim biosimilar candidate, which is used for the treatment of febrile neutropenia; CHS-0214, an etanercept biosimilar candidate, which is in various phases of clinical trials for the treatment of ankylosing spondylitis, juvenile idiopathic arthritis, psoriatic arthritis, rheumatoid arthritis, and psoriasis; and CHS-5217, a bevacizumab biosimilar candidate, which is in preclinical stage for the treatment of metastatic colorectal cancer, nonsmall cell lung cancer, metastatic kidney cancer, advanced cervical cancer, platinum-resistant ovarian cancer, and recurrent glioblastoma. Its product candidates also comprise CHS-1420, an adalimumab biosimilar candidate, which is in various phases of clinical trials to treat ankylosing spondylitis, Behcet's Disease, Crohn's Disease, juvenile idiopathic arthritis, psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis; and CHS-3351, a ranibizumab biosimilar candidate, which is in preclinical stage for the treatment of neovascular (wet) age-related macular, degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy. Coherus Biosciences, Inc. has license agreement with Daiichi Sankyo Company, Limited; Baxalta Incorporated, Baxalta US Inc., and Baxalta GmbH; Genentech, Inc.; and Selexis SA. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus Biosciences, Inc. in April 2012. Coherus Biosciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Ticker WUBA [NYSE]
Company 58.com Inc.
Country China
Industry Internet Information Providers
Market Cap 7.77B EPS (ttm) -0.27
P/E - EPS this Y 59.20%
Forward P/E 29.39 EPS next Y 112.93%
PEG - EPS past 5Y -6.10%
P/S 6.43 EPS next 5Y -
P/B 2.90 EPS Q/Q 96.10%
Dividend - Sales Q/Q 31.70%
Insider Own 14.03% Inst Own 80.10%
Insider Trans 0.00% Inst Trans -3.73%
Short Float 83.42% Earnings Aug 21/b
Analyst Recom 2.70 Target Price 48.47
Avg Volume 1.34M 52W Range 27.58 - 55.79
Aug-21-17 12:52PM Chinese Stock Is Gaining Ground GuruFocus.com
Aug-21-17 12:34PM Why Shares of 58.com Are Soaring Today Motley Fool
Aug-21-17 06:30AM Investor Network: 58.com Inc. Sponsored ADR Class A to Host Earnings Call ACCESSWIRE
Aug-20-17 08:00PM 58.com Reports Second Quarter 2017 Unaudited Financial Results PR Newswire
Aug-15-17 06:00AM 58.com Inc. to Report Second Quarter 2017 Financial Results on August 21, 2017 PR Newswire
Jul-11-17 04:09PM As Alibaba Climbs, This Other Chinese Stock Tests New Buy Zone Investor's Business Daily
Jul-11-17 03:13PM ETFs with exposure to 58.com Inc. : July 11, 2017 Capital Cube
Jul-05-17 01:00PM Can These Momentum Stocks Break Out One More Time? Investopedia
Jun-30-17 03:06PM After Alibaba, Weibo Moves, This Chinese Stock May Be Setting Up Investor's Business Daily
Jun-28-17 08:30AM 58.com Files Amendment No. 1 to Form 20-F for Fiscal Year 2016 PR Newswire


58.com Inc. operates online classifieds and listing platforms that enable local merchants and consumers to connect, share information, and conduct business in China. It primarily operates online multi-content category-classified advertising platforms under the 58 and Ganji names; and Anjuke, an online real estate listing platform. The company's platform contains local information of approximately 500 cities or towns in various content categories, including jobs, real estate, used goods, automotive, and yellow pages. It offers membership services, such as merchant certification and listing benefits, as well as display of online storefronts; and online marketing services comprising listing services, such as real-time bidding and priority listing, as well as marketing services through collaboration with third party Internet companies. 58.com Inc. was founded in 2005 and is headquartered in Beijing, the People's Republic of China.



Ticker XPLR [NASD]


Company Xplore Technologies Corp.
Country USA
Industry Diversified Computer Systems
Market Cap 35.30M EPS (ttm) -0.23
P/E - EPS this Y -599.20%
Forward P/E 21.33 EPS next Y 782.35%
PEG - EPS past 5Y 52.80%
P/S 0.45 EPS next 5Y 10.00%
P/B 1.20 EPS Q/Q -
Dividend - Sales Q/Q 21.20%
Insider Own 5.10% Inst Own 33.70%
Insider Trans 7.79% Inst Trans -11.01%
Short Float 0.89% Earnings Aug 09/a
Analyst Recom 2.00 Target Price 4.62
Avg Volume 73.38K 52W Range 1.54 - 3.38


Aug-18-17 10:01AM Top Ranked Momentum Stocks to Buy for August 18th Zacks
Aug-16-17 01:15PM Xplore Technologies Appoints Robert McFarland to Its Board of Directors GlobeNewswire
Aug-15-17 09:39AM Xplore and DCT Solutions Partner to Give Vital Farms a Technology Edge in Organic Agricultural Sector GlobeNewswire
Aug-13-17 03:26AM Edited Transcript of XPLR earnings conference call or presentation 9-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-17 04:05PM Xplore Technologies Reports Profitable First Quarter Results GlobeNewswire
Aug-08-17 09:00AM Xplore Rugged Tablets Driving Data Collection Efforts for Net Zero Deforestation Project in Colombia GlobeNewswire
Aug-01-17 09:00AM Xplore and Digicel Partner to Improve Field Inspection Capabilities for Latin America Energy Company with New Android Rugged Tablet Deployment GlobeNewswire
Jul-27-17 09:00AM Xplore Technologies to Announce Fiscal First Quarter 2018 Financial Results on August 9 GlobeNewswire
Jul-26-17 09:00AM Xplore Secures New Workforce Mobility Project with Major Telecommunications Provider GlobeNewswire
Jul-18-17 09:00AM Xplore Offers Dramatically Increased Performance for Category-Leading 12 Rugged Tablet with New Intel® PCIe Solid State Drives GlobeNewswire


Xplore Technologies Corp. develops, integrates, and markets rugged mobile personal computer systems in the United States, Canada, and internationally. The company's products enable the extension of traditional computing systems to a range of field personnel, including energy pipeline inspectors, public safety personnel, warehouse workers, and pharmaceutical scientists. It offers a line of iX104 tablet PCs that are designed to operate in various work environments, such as extreme temperatures, constant vibrations, rain, and blowing dirt and dusty conditions; and are fitted with a range of performance matched accessories comprising multiple docking station solutions, wireless connectivity alternatives, global positioning system modules, and biometric and smartcard modules, as well as traditional peripherals, such as keyboards, mice, and cases. The company's products also consist of XSlate B10 and XSlate D10 rugged tablets; XSLATE R12 and Motion F5m/C5m tablets; and Bobcat, a rugged tablet that has a Windows operating system. It serves public safety, utility, telecommunications, field service, warehousing logistics, transportation, oil and gas production, manufacturing, route delivery, military, and homeland security markets. The company was founded in 1998 and is headquartered in Austin, Texas.